122 related articles for article (PubMed ID: 10694326)
21. Disabled-2 inactivation is an early step in ovarian tumorigenicity.
Fazili Z; Sun W; Mittelstaedt S; Cohen C; Xu XX
Oncogene; 1999 May; 18(20):3104-13. PubMed ID: 10340382
[TBL] [Abstract][Full Text] [Related]
22. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.
Nunez MI; Rosen DG; Ludes-Meyers JH; Abba MC; Kil H; Page R; Klein-Szanto AJ; Godwin AK; Liu J; Mills GB; Aldaz CM
BMC Cancer; 2005 Jun; 5():64. PubMed ID: 15982416
[TBL] [Abstract][Full Text] [Related]
23. HOX cofactors expression and regulation in the human ovary.
Ota T; Asahina H; Park SH; Huang Q; Minegishi T; Auersperg N; Leung PC
Reprod Biol Endocrinol; 2008 Oct; 6():49. PubMed ID: 18973687
[TBL] [Abstract][Full Text] [Related]
24. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
25. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
26. Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines.
King BL; Carter D; Foellmer HG; Kacinski BM
Am J Pathol; 1992 Jan; 140(1):23-31. PubMed ID: 1346236
[TBL] [Abstract][Full Text] [Related]
27. Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer.
Paley PJ; Goff BA; Gown AM; Greer BE; Sage EH
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):336-41. PubMed ID: 10985890
[TBL] [Abstract][Full Text] [Related]
28. Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis.
Urieli-Shoval S; Finci-Yeheskel Z; Dishon S; Galinsky D; Linke RP; Ariel I; Levin M; Ben-Shachar I; Prus D
J Histochem Cytochem; 2010 Nov; 58(11):1015-23. PubMed ID: 20713982
[TBL] [Abstract][Full Text] [Related]
29. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.
Weichert W; Denkert C; Schmidt M; Gekeler V; Wolf G; Köbel M; Dietel M; Hauptmann S
Br J Cancer; 2004 Feb; 90(4):815-21. PubMed ID: 14970859
[TBL] [Abstract][Full Text] [Related]
30. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC
J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
32. Differential gene expression between normal and tumor-derived ovarian epithelial cells.
Ismail RS; Baldwin RL; Fang J; Browning D; Karlan BY; Gasson JC; Chang DD
Cancer Res; 2000 Dec; 60(23):6744-9. PubMed ID: 11118061
[TBL] [Abstract][Full Text] [Related]
33. The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia.
Song JY; Chen KY; Kim SY; Kim MR; Ryu KS; Cha JH; Kang CS; MacLaughlin DT; Kim JH
Int J Oncol; 2009 Jun; 34(6):1583-91. PubMed ID: 19424576
[TBL] [Abstract][Full Text] [Related]
34. Estrogen effects on the expression of Brx in the brain and pituitary of the mouse.
Eddington DO; Baldwin EL; Segars JH; Wu TJ
Brain Res Bull; 2006 Apr; 69(4):447-51. PubMed ID: 16624676
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of cysteine cathepsins in ovarian tissue from chickens with ovarian cancer.
Ahn SE; Choi JW; Rengaraj D; Seo HW; Lim W; Han JY; Song G
Reprod Biol Endocrinol; 2010 Aug; 8():100. PubMed ID: 20727192
[TBL] [Abstract][Full Text] [Related]
36. Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties.
Kämäräinen M; Leivo I; Koistinen R; Julkunen M; Karvonen U; Rutanen EM; Seppälä M
Am J Pathol; 1996 May; 148(5):1435-43. PubMed ID: 8623915
[TBL] [Abstract][Full Text] [Related]
37. The silence of the genes: matching mismatch repair defects with tumors.
Boland CR; Goel A
Cancer; 2003 Nov; 98(10):2091-4. PubMed ID: 14601077
[No Abstract] [Full Text] [Related]
38. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues.
Lee H; Maihle NJ
Oncogene; 1998 Jun; 16(25):3243-52. PubMed ID: 9681822
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of lysosome-associated protein transmembrane-4 beta (LAPTM4B) in granulosa cells of ovarian follicles and in other bovine tissues.
Ndiaye K; Carrière PD; Sirois J; Silversides DW; Lussier JG
J Ovarian Res; 2015 Mar; 8():12. PubMed ID: 25881887
[TBL] [Abstract][Full Text] [Related]
40. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
